Population-based study of the risk of second primary contralateral breast cancer associated with carrying a mutation in BRCA1 or BRCA2 Academic Article uri icon

Overview

MeSH Major

  • BRCA1 Protein
  • BRCA2 Protein
  • Breast Neoplasms
  • Mutation
  • Neoplasm Recurrence, Local

abstract

  • The risks of subsequent contralateral breast cancer are substantial for women who carry a BRCA1/BRCA2 mutation. These findings have important clinical relevance regarding the assessment of BRCA1/BRCA2 status in patients with breast cancer and the counseling and clinical management of patients found to carry a mutation.

publication date

  • May 10, 2010

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC2881721

Digital Object Identifier (DOI)

  • 10.1200/JCO.2009.24.2495

PubMed ID

  • 20368571

Additional Document Info

start page

  • 2404

end page

  • 10

volume

  • 28

number

  • 14